Cartography Biosciences

Cartography Biosciences

Executive Director/Vice President, Finance & Controller

South San Francisco, CA · Exec

Sponsorship not specifiedDetected 14 days ago
Machine LearningComplianceFinancial ModelingFinancial AnalysisAccountingForecastingBudgetingQuickBooksValuationFP&ALeadershipCommunicationPublic SpeakingAdaptabilityOrganizational SkillsGAAPFinancial ReportingAccounts PayableNetSuite

About the role

  • You will oversee all aspects of financial reporting, accounting, treasury, tax, risk management, financial planning and analysis, and compliance.
  • The successful candidate will be comfortable operating strategically while being hands-on with the day-to-day finance and accounting operations.
  • The position will report to the CFO when the role is filled and will initially report to the CEO; title for the position will be based on experience.

Responsibilities

  • The Executive Director/Vice President, Finance & Controller will serve as a trusted business partner responsible for ensuring financial integrity, operational excellence, and strategic decision support.
  • In short, this is a highly visible, senior leadership role collaborating cross-functionally to help guide the future growth of the organization and support corporate initiatives.
  • Manage the financial close process and preparation of financial statements in accordance with US GAAP, ensuring accuracy and timeliness Prepare and review management reports, investor reporting, and Board level financial packages.

Nice to have

  • Bachelor's degree in finance, accounting, or related field
  • effective on teams as well as individually

Compensation

  • Oversee general ledger, accounts payable, payroll, accounts receivable, and treasury functions Deliver financial presentations to senior leadership, including annual budget summaries and quarterly financial reports.

Company info

  • About Cartography Biosciences Cartography Biosciences is advancing a differentiated oncology pipeline of antibody-based therapies designed to target tumors with unprecedented precision.
  • The company's ATLAS and SUMMIT discovery platforms are powered by an industry-leading, fully integrated dataset spanning hundreds of thousands of cell states across healthy tissues alongside large-scale single-cell profiling of patient tumors.
  • By combining petabyte-scale proprietary data, machine learning, and AI-driven biological insights, Cartography is identifying highly specific tumor targets and logic-gated target combinations to generate therapies engineered for maximal tumor selectivity and meaningful patient impact.
  • The company's lead program, CBI-1214, is a T-cell engager in development for colorectal cancer.
  • CBI-1214 entered the clinic in early 2026 and is currently enrolling and treating patients in a phase 1 trial.
Apply directly at Cartography Biosciences →Create a free account for alerts like thisView Cartography Biosciences immigration profile

This listing is sourced directly from Cartography Biosciences's careers page and normalized into a canonical job model.